Symbols / NOTV Stock $0.29 -4.38% Inotiv, Inc.

Healthcare • Diagnostics & Research • United States • NCM
NOTV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Stock Fundamentals
Scroll to Statements
Market Cap 9.91M Enterprise Value 473.60M Income -69.37M Sales 514.03M Book/sh 3.17 Cash/sh 0.37
Dividend Yield — Payout 0.00% Employees 1945 IPO — P/E — Forward P/E -5.76
PEG — P/S 0.02 P/B 0.09 P/C — EV/EBITDA 26.79 EV/Sales 0.92
Quick Ratio 0.17 Current Ratio 0.30 Debt/Eq 436.57 LT Debt/Eq — EPS (ttm) -1.92 EPS next Y -0.05
EPS Growth — Revenue Growth 0.80% Earnings 2026-05-06 ROA -3.14% ROE -49.76% ROIC —
Gross Margin 23.49% Oper. Margin -13.36% Profit Margin -13.50% Shs Outstand 34.40M Shs Float 31.82M Short Float 8.56%
Short Ratio 6.16 Short Interest — 52W High 3.32 52W Low 0.22 Beta 4.08 Avg Volume 691.31K
Volume 95.15K Target Price $3.25 Recom None Prev Close $0.30 Price $0.29 Change -4.38%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.25
Mean price target
2. Current target
$0.29
Latest analyst target
3. DCF / Fair value
$-1.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.29
Low
$1.50
High
$5.00
Mean
$3.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-10 main Lake Street Buy → Buy $2
2025-12-04 main Lake Street Buy → Buy $3
2025-05-08 main Lake Street Buy → Buy $5
2024-09-30 up Lake Street Hold → Buy $4
2024-05-16 down Lake Street Buy → Hold $2
2024-05-16 main Craig-Hallum Buy → Buy $10
2024-05-14 down Jefferies Buy → Hold $4
2024-02-09 up Jefferies Hold → Buy $12
2023-12-12 main Craig-Hallum Buy → Buy $25
2023-07-20 init Wells Fargo — → Overweight $9
2023-01-19 down Jefferies Buy → Hold $8
2023-01-11 up Lake Street Hold → Buy $10
2022-11-18 down Lake Street Buy → Hold $7
2022-10-04 init Jefferies — → Buy $27
2022-08-11 main Lake Street — → Buy $60
2022-01-31 init Lake Street — → Buy $60
2021-09-20 init Craig-Hallum — → Buy $45
News
RSS: Latest NOTV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-17 TAYLOR BETH A Chief Financial Officer — 2,888 $0.29 $846
2026-02-17 SAGARTZ JOHN E Officer — 2,119 $0.29 $616
2026-02-17 LEASURE ROBERT JR. Chief Executive Officer — 16,810 $0.30 $4,964
2026-02-02 LEASURE ROBERT JR. Chief Executive Officer — 113,297 $0.50 $57,034
2025-12-01 NEFF R MATTHEW Director — 2,000 $0.89 $1,771
2025-11-03 NEFF R MATTHEW Director — 2,000 $1.24 $2,487
2025-10-24 NEFF R MATTHEW Director — 10,000 $1.94 $19,400
2025-10-01 NEFF R MATTHEW Director — 2,000 $1.43 $2,858
2025-09-02 NEFF R MATTHEW Director — 2,000 $1.67 $3,338
2025-08-01 NEFF R MATTHEW Director — 2,000 $1.91 $3,818
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
513.02
+4.54%
490.74
-14.27%
572.42
+4.52%
547.66
Operating Revenue
513.02
+4.54%
490.74
-14.27%
572.42
+4.52%
547.66
Cost Of Revenue
392.04
+3.29%
379.57
-2.80%
390.48
+0.01%
390.44
Reconciled Cost Of Revenue
392.04
+3.29%
379.57
-2.80%
390.48
+4.97%
372.01
Gross Profit
120.98
+8.82%
111.17
-38.90%
181.94
+15.73%
157.21
Operating Expense
157.98
-4.62%
165.63
-13.36%
191.18
+39.59%
136.96
Research And Development
—
—
—
—
Selling General And Administration
92.24
-5.79%
97.92
-20.89%
123.78
+24.92%
99.09
Selling And Marketing Expense
21.14
+1.25%
20.88
+9.48%
19.07
+14.56%
16.65
General And Administrative Expense
71.10
-7.70%
77.03
-26.43%
104.71
+27.01%
82.44
Other Gand A
71.10
-7.70%
77.03
-26.43%
104.71
+27.01%
82.44
Other Operating Expenses
9.81
-7.47%
10.60
-16.45%
12.68
+81.54%
6.99
Total Expenses
550.02
+0.88%
545.20
-6.27%
581.66
+10.29%
527.40
Operating Income
-37.00
+32.07%
-54.46
-489.42%
-9.24
-145.63%
20.25
Total Operating Income As Reported
-30.90
+64.24%
-86.41
-6.07%
-81.46
+69.08%
-263.45
EBITDA
24.75
+192.51%
-26.76
-0.95%
-26.51
+90.31%
-273.42
Normalized EBITDA
18.66
+259.76%
5.19
-88.66%
45.71
+344.60%
10.28
Reconciled Depreciation
55.93
-2.08%
57.12
+4.39%
54.72
+10.93%
49.32
EBIT
-31.18
+62.83%
-83.88
-3.27%
-81.22
+74.83%
-322.75
Total Unusual Items
6.10
+119.08%
-31.94
+55.77%
-72.22
+74.54%
-283.70
Total Unusual Items Excluding Goodwill
6.10
+119.08%
-31.94
+55.77%
-72.22
+74.54%
-283.70
Special Income Charges
6.10
+119.08%
-31.94
+55.77%
-72.22
+74.54%
-283.70
Other Special Charges
-7.55
-126.49%
28.50
—
—
Impairment Of Capital Assets
0.00
0.00
-100.00%
66.37
-71.88%
236.00
Restructuring And Mergern Acquisition
1.45
-57.78%
3.44
-41.16%
5.85
-87.73%
47.70
Net Income
-68.62
+36.72%
-108.44
-3.14%
-105.14
+68.80%
-337.02
Pretax Income
-87.77
+32.88%
-130.76
-5.25%
-124.24
+64.75%
-352.45
Net Non Operating Interest Income Expense
-56.59
-20.71%
-46.88
-8.98%
-43.02
-44.83%
-29.70
Interest Expense Non Operating
56.59
+20.71%
46.88
+8.98%
43.02
+44.83%
29.70
Net Interest Income
-56.59
-20.71%
-46.88
-8.98%
-43.02
-44.83%
-29.70
Interest Expense
56.59
+20.71%
46.88
+8.98%
43.02
+44.83%
29.70
Other Income Expense
5.82
+119.80%
-29.41
+59.14%
-71.98
+79.01%
-343.00
Other Non Operating Income Expenses
-0.27
-110.79%
2.53
+967.51%
0.24
+100.40%
-59.29
Gain On Sale Of Security
—
—
0.76
—
Tax Provision
-19.14
+12.49%
-21.88
-13.11%
-19.34
-27.35%
-15.19
Tax Rate For Calcs
0.00
+30.54%
0.00
+7.05%
0.00
+262.79%
0.00
Tax Effect Of Unusual Items
1.33
+124.91%
-5.33
+52.65%
-11.27
+7.65%
-12.20
Net Income Including Noncontrolling Interests
-68.62
+36.97%
-108.89
-3.80%
-104.90
+68.90%
-337.26
Net Income From Continuing Operation Net Minority Interest
-68.62
+36.72%
-108.44
-3.14%
-105.14
+68.80%
-337.02
Net Income From Continuing And Discontinued Operation
-68.62
+36.72%
-108.44
-3.14%
-105.14
+68.80%
-337.02
Net Income Continuous Operations
-68.62
+36.97%
-108.89
-3.80%
-104.90
+68.90%
-337.26
Minority Interests
0.00
-100.00%
0.44
+284.87%
-0.24
-197.54%
0.24
Normalized Income
-73.39
+10.32%
-81.84
-85.21%
-44.19
+32.55%
-65.51
Net Income Common Stockholders
-68.62
+36.72%
-108.44
-3.14%
-105.14
+68.80%
-337.02
Diluted EPS
-2.11
+49.64%
-4.19
-2.20%
-4.10
+70.38%
-13.84
Basic EPS
-2.11
+49.64%
-4.19
-2.20%
-4.10
+70.38%
-13.84
Basic Average Shares
32.45
+25.31%
25.90
+1.00%
25.64
+5.28%
24.35
Diluted Average Shares
32.45
+25.31%
25.90
+1.00%
25.64
+5.28%
24.35
Diluted NI Availto Com Stockholders
-68.62
+36.72%
-108.44
-3.14%
-105.14
+68.80%
-337.02
Average Dilution Earnings
—
—
—
—
Amortization
55.93
-2.08%
57.12
+4.39%
54.72
+77.15%
30.89
Amortization Of Intangibles Income Statement
55.93
-2.08%
57.12
+4.39%
54.72
+77.15%
30.89
Depreciation Amortization Depletion Income Statement
55.93
-2.08%
57.12
+4.39%
54.72
+77.15%
30.89
Depreciation And Amortization In Income Statement
55.93
-2.08%
57.12
+4.39%
54.72
+77.15%
30.89
Line Item Trend 2023-09-30
Total Assets
856.53
Current Assets
213.80
Cash Cash Equivalents And Short Term Investments
35.49
Cash And Cash Equivalents
35.49
Receivables
90.42
Accounts Receivable
77.62
Gross Accounts Receivable
—
Allowance For Doubtful Accounts Receivable
—
Receivables Adjustments Allowances
-7.45
Other Receivables
17.21
Taxes Receivable
1.81
Inventory
56.10
Raw Materials
2.26
Work In Process
0.12
Finished Goods
4.44
Prepaid Assets
23.55
Restricted Cash
0.00
Assets Held For Sale Current
1.42
Other Current Assets
6.82
Total Non Current Assets
642.73
Net PPE
229.93
Gross PPE
304.57
Accumulated Depreciation
-74.64
Properties
0.00
Land And Improvements
30.71
Buildings And Improvements
120.93
Machinery Furniture Equipment
84.59
Construction In Progress
25.80
Other Properties
42.53
Goodwill And Other Intangible Assets
402.71
Goodwill
94.29
Other Intangible Assets
308.43
Non Current Prepaid Assets
3.68
Other Non Current Assets
3.36
Total Liabilities Net Minority Interest
588.04
Current Liabilities
132.19
Payables And Accrued Expenses
40.13
Payables
37.16
Accounts Payable
32.56
Other Payable
—
Current Accrued Expenses
2.98
Pensionand Other Post Retirement Benefit Plans Current
12.97
Total Tax Payable
4.60
Current Debt And Capital Lease Obligation
18.23
Current Debt
7.95
Other Current Borrowings
7.95
Current Capital Lease Obligation
10.28
Current Deferred Liabilities
55.62
Current Deferred Revenue
55.62
Other Current Liabilities
5.24
Total Non Current Liabilities Net Minority Interest
455.85
Long Term Debt And Capital Lease Obligation
399.41
Long Term Debt
369.80
Long Term Capital Lease Obligation
29.61
Defined Pension Benefit
3.04
Non Current Deferred Liabilities
50.06
Non Current Deferred Revenue
—
Non Current Deferred Taxes Liabilities
50.06
Other Non Current Liabilities
6.37
Stockholders Equity
269.15
Common Stock Equity
269.15
Capital Stock
6.41
Common Stock
6.41
Preferred Stock
—
Share Issued
25.78
Ordinary Shares Number
25.78
Treasury Shares Number
0.00
Additional Paid In Capital
715.70
Retained Earnings
-453.28
Gains Losses Not Affecting Retained Earnings
0.33
Minority Interest
-0.66
Other Equity Adjustments
0.33
Total Equity Gross Minority Interest
268.49
Total Capitalization
638.95
Working Capital
81.61
Invested Capital
646.90
Total Debt
417.64
Net Debt
342.25
Capital Lease Obligations
39.90
Net Tangible Assets
-133.56
Tangible Book Value
-133.56
Interest Payable
2.98
Inventories Adjustments Allowances
-3.24
Line Of Credit
0.00
Non Current Note Receivables
—
Notes Receivable
1.23
Other Inventories
52.52
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-10.46
-53.64%
-6.80
-124.41%
27.88
+634.46%
-5.22
Cash Flow From Continuing Operating Activities
-10.46
-53.64%
-6.80
-124.41%
27.88
+634.46%
-5.22
Net Income From Continuing Operations
-68.62
+36.97%
-108.89
-3.80%
-104.90
+68.90%
-337.26
Depreciation Amortization Depletion
55.93
-2.08%
57.12
+4.39%
54.72
+10.93%
49.32
Depreciation
—
—
—
—
Depreciation And Amortization
55.93
-2.08%
57.12
+4.39%
54.72
+10.93%
49.32
Other Non Cash Items
19.46
+82.38%
10.67
-6.71%
11.44
-49.40%
22.61
Stock Based Compensation
6.03
-10.56%
6.74
-14.07%
7.84
-67.59%
24.20
Provisionand Write Offof Assets
-0.49
-948.28%
0.06
-95.44%
1.27
-2.53%
1.31
Asset Impairment Charge
0.00
0.00
-100.00%
66.37
-71.88%
236.00
Deferred Tax
-21.61
+7.05%
-23.25
+9.91%
-25.81
-44.72%
-17.84
Deferred Income Tax
-21.61
+7.05%
-23.25
+9.91%
-25.81
-44.72%
-17.84
Operating Gains Losses
—
-1.86
—
56.71
Gain Loss On Investment Securities
—
—
—
56.71
Change In Working Capital
-1.14
-102.17%
52.60
+210.24%
16.96
+142.10%
-40.28
Change In Receivables
-3.83
-127.03%
14.17
+48.36%
9.55
+140.06%
-23.84
Changes In Account Receivables
-3.83
-127.03%
14.17
+48.36%
9.55
+140.06%
-23.84
Change In Inventory
-27.59
-172.20%
38.21
+172.71%
14.01
+139.81%
-35.20
Change In Prepaid Assets
2.50
+115.29%
-16.36
-245.41%
11.25
+156.09%
-20.05
Change In Payables And Accrued Expense
26.39
+852.33%
2.77
+216.62%
-2.38
-135.89%
6.62
Change In Accrued Expense
14.05
+551.25%
2.16
+125.88%
-8.34
-156.87%
14.66
Change In Payable
12.34
+1912.23%
0.61
-89.72%
5.96
+174.15%
-8.04
Change In Account Payable
12.34
+1912.23%
0.61
-89.72%
5.96
+174.15%
-8.04
Change In Other Working Capital
1.38
-89.99%
13.81
+189.24%
-15.48
-148.08%
32.19
Investing Cash Flow
-12.89
+23.41%
-16.83
+41.46%
-28.75
+91.38%
-333.72
Cash Flow From Continuing Investing Activities
-12.89
+23.41%
-16.83
+41.46%
-28.75
+91.38%
-333.72
Net PPE Purchase And Sale
3.72
-32.02%
5.48
+391.30%
1.11
+284.48%
0.29
Sale Of PPE
3.72
-32.02%
5.48
+391.30%
1.11
+284.48%
0.29
Capital Expenditure
-16.61
+25.53%
-22.31
+18.88%
-27.50
+24.23%
-36.30
Capital Expenditure Reported
-16.61
+25.53%
-22.31
+18.88%
-27.50
+24.23%
-36.30
Net Business Purchase And Sale
—
—
0.00
+100.00%
-297.71
Purchase Of Business
—
—
0.00
+100.00%
-297.71
Net Other Investing Changes
—
—
-2.37
—
Financing Cash Flow
23.70
+144.97%
9.68
-39.04%
15.87
-92.19%
203.15
Cash Flow From Continuing Financing Activities
23.70
+144.97%
9.68
-39.04%
15.87
-92.19%
203.15
Net Issuance Payments Of Debt
-1.95
-114.36%
13.55
-24.45%
17.93
-91.63%
214.26
Issuance Of Debt
26.00
-10.34%
29.00
-29.27%
41.00
-85.04%
274.00
Repayment Of Debt
-27.95
-80.83%
-15.45
+33.01%
-23.07
+61.38%
-59.74
Long Term Debt Issuance
26.00
-10.34%
29.00
-29.27%
41.00
-82.92%
240.00
Long Term Debt Payments
-27.95
-80.83%
-15.45
+33.01%
-23.07
+43.38%
-40.74
Net Long Term Debt Issuance
-1.95
-114.36%
13.55
-24.45%
17.93
-91.00%
199.26
Short Term Debt Issuance
—
—
6.00
-82.35%
34.00
Short Term Debt Payments
—
—
-21.00
-10.53%
-19.00
Net Short Term Debt Issuance
—
—
-15.00
-200.00%
15.00
Net Common Stock Issuance
27.52
0.00
0.00
0.00
Proceeds From Stock Option Exercised
—
—
0.11
-6.78%
0.12
Net Other Financing Charges
-1.88
+51.49%
-3.87
-88.10%
-2.06
+81.66%
-11.22
Changes In Cash
0.35
+102.54%
-13.96
-193.08%
15.00
+111.05%
-135.79
Effect Of Exchange Rate Changes
-0.05
+53.06%
-0.10
-106.48%
1.51
+170.13%
-2.16
Beginning Cash Position
21.43
-39.61%
35.49
+87.00%
18.98
-87.90%
156.92
End Cash Position
21.74
+1.44%
21.43
-39.61%
35.49
+87.00%
18.98
Free Cash Flow
-27.07
+7.02%
-29.11
-7761.84%
0.38
+100.92%
-41.52
Interest Paid Supplemental Data
38.84
+7.47%
36.14
+1.91%
35.46
+107.81%
17.06
Income Tax Paid Supplemental Data
0.75
-59.36%
1.84
-74.21%
7.15
+1391.86%
0.48
Change In Income Tax Payable
—
—
—
—
Change In Tax Payable
—
—
—
—
Common Stock Issuance
27.52
0.00
0.00
0.00
Issuance Of Capital Stock
27.52
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category